
Corporate Governance11 Nov 2026, 06:20 pm
Jeevan Scientific: No deviation in preferential allotment funds
AI Summary
Jeevan Scientific Technology Ltd has reported that there were no deviations or variations in the utilization of funds raised through a preferential allotment during the quarter ended September 30, 2026. The company raised ₹3,074 Lakhs (₹30.74 Crore) on January 2, 2026. The funds were allocated across various purposes including Capital Expenditure, Working Capital, acquisition of API/formulation units, and General Corporate Purposes. The actual utilization for these purposes during the quarter was within the allocated amounts, with no significant variances reported.
Key Highlights
- No deviation reported in preferential allotment fund utilization for Q3 FY27.
- Total funds raised via preferential allotment: ₹3,074 Lakhs (₹30.74 Crore).
- Funds utilized for capital expenditure, working capital, and acquisitions.
- No shareholder approval required for any deviation.
Price Impact
More from JSTL